Zymeworks completes $8.1 Million financing round

Vancouver's Zymeworks announced today the completion of a $8.1 Million financing round. The financing consists of a follow-on round of institutional investment by Montreal's CTI Life Sciences Fund, as well as a new investment by Advanced Biotechnologies Venture Fund and investments by several existing private shareholders.

Zymeworks will use the proceeds to advance its Azymetric and AlbuCORE platforms, as well as the development of Zymeworks' best-in-class protein therapeutics pipeline in the areas of cancer, autoimmunity and inflammatory diseases.

Zymeworks Inc
Vancouver, British Columbia, Canada

Zymeworks is a privately held biotechnology company developing proprietary biocatalyst (enzyme) engineering technologies to create novel process development solutions for industrial, specialty chemical and pharmaceutical manufacturing. The cornerstone of Zymeworks' science & technology is its unique molecular modeling platform that enables the company to accurately simulate the physical and... more

blog comments powered by Disqus

Techvibes NewsDesk

Techvibes NewsDesk

Techvibes is Canada's leading technology media property.Founded in 2002, Techvibes covers technology and business news that impacts Canadians. We combine breaking local news with international coverage to deliver a unique balance of insight and information. The Techvibes Newsdesk covers a broad beat and publishes general news stories. If you have a story you would like covered, email... more

Who's Hiring

Recent Comments

Powered by Disqus